Mirum Pharmaceuticals MIRM Earnings Call Transcripts

NASDAQ MIRM
$94.42 +1.24 (+1.33%)
At close: Nov 10, 2026 · 4:00 PM EST
7 earnings calls on file for Mirum Pharmaceuticals, from Q1 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Mirum Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 5,779 words · 25 min read
  • Andrew McKibbenSenior Vice President of Strategic Finance and Investor Relations
  • Christopher PeetzChief Executive Officer
  • Peter RadovichPresident and Chief Operating Officer
  • Rob MyersChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Mirum Pharmaceuticals Earnings Call Transcripts

Calls7
LatestNov 3, 2026
SinceQ1 2025

Fiscal 2026

Fiscal 2025

All 7 Mirum Pharmaceuticals transcripts Register to get access to Mirum Pharmaceuticals’s earnings call transcripts.